Shopping Cart
- Remove All
- Your shopping cart is currently empty
Fluorofenidone (AKF-PD) attenuates the progression of renal interstitial fibrosis partly by suppressing NADPH oxidase and extracellular matrix (ECM) deposition via the PI3K/Akt signalling pathway. Fluorofenidone is an analogue of AMR69. Which displays equivalent lower toxicity, antifibrotic activity, and longer half-life.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $30 | In Stock | |
5 mg | $47 | In Stock | |
10 mg | $77 | In Stock | |
25 mg | $158 | In Stock | |
50 mg | $287 | In Stock | |
100 mg | $413 | In Stock | |
200 mg | $582 | In Stock | |
1 mL x 10 mM (in DMSO) | $52 | In Stock |
Description | Fluorofenidone (AKF-PD) attenuates the progression of renal interstitial fibrosis partly by suppressing NADPH oxidase and extracellular matrix (ECM) deposition via the PI3K/Akt signalling pathway. Fluorofenidone is an analogue of AMR69. Which displays equivalent lower toxicity, antifibrotic activity, and longer half-life. |
Alias | AKF-PD |
Molecular Weight | 203.21 |
Formula | C12H10FNO |
Cas No. | 848353-85-5 |
Smiles | Cc1ccc(=O)n(c1)-c1cccc(F)c1 |
Relative Density. | no data available |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 15 mg/mL (73.82 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.